SecBot SecBot

BIO-B

BIO-RAD LABORATORIES, INC.
NYSE· Laboratory Analytical Instruments· Inc. DE· CIK 0000012208 Industrials & Manufacturing
$364.15 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $364.15
Market cap
$9.7B
Mid cap
1 year
+13.4%
from $321.12 · Oct 27
30 days
−0.3%
from $365.08
52-week range
$255.54–365.08
−0% from high · low May 8
Avg volume 20D
10
Oct 14 spike 200
Short interest
1
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Jun 15 Short interest falls 98.9% to 1
  • X Jun 30 Short interest jumps 21900.0% to 220
  • X Jul 15 Short interest falls 85.9% to 31
  • X Jul 31 Short interest falls 93.5% to 2

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q1 2026: 1 added (0 new), 0 trimmed or exited.

  • TrendRANGE

    0% above its 50-day average.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD13$3.6K
UBS Group AGDOUBLED3$716.00

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
1
shares short
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Apr 24, 2026 SEC
Bio-Rad Laboratories amended its 2017 Incentive Award Plan, increasing the share reserve by 335,000 shares and…
8-K — Impact 4/10
Mar 31, 2026 Inst.
UBS Group AG — ADD
13 shares ($3.6K)
Jun 30, 2025 Inst.
UBS Group AG — DOUBLED
3 shares ($716.00)

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All BIO-B filing & press-release reports (1)